Jomori Takahiro, Higa Nanami, Tyas Trianda Ayuning, Matsuura Natsuki, Ueda Yudai, Suetake Ayumi, Miyazaki Shin, Watanabe Shuichi, Arizono Sei, Hayashi Yasuhiro, Yasumoto Ko, Ise Yuji, Wakimoto Toshiyuki, Yasumoto-Hirose Mina, Tanaka Junichi, Mori-Yasumoto Kanami
Department of Chemistry, Biology and Marine Science, Faculty of Science, University of the Ryukyus, Nishihara, Okinawa, 903-0213, Japan.
Faculty of Pharmaceutical Sciences, Tokyo University of Science, Niijuku, Tokyo, Katushika, 125-8585, Japan.
Mar Biotechnol (NY). 2025 Sep 5;27(5):132. doi: 10.1007/s10126-025-10494-1.
Leishmaniasis is a neglected tropical disease posing significant global health challenges. Given the limited effective treatment options and associated constraints, many patients are unable to complete therapy. In this study, we report the remarkable leishmanicidal activity of onnamides derived from the marine sponge Theonella sp. against the promastigote form of Leishmania major (IC = 0.2-140 nM) and demonstrate their selectivity through cytotoxicity assessments on human hepatoma HepG2 cells. Structural-activity relationship (SAR) analyses were conducted using 6,7-dihydro-onnamide A and its analogs. Furthermore, we compared the action mechanisms of amphotericin B, the primary drug currently used for treatment, and the obtained onnamides. Based on biological evaluations and SAR studies, onnamides can be considered promising candidates for anti-leishmanial chemotherapy, warranting further investigation.
利什曼病是一种被忽视的热带疾病,给全球健康带来重大挑战。鉴于有效的治疗选择有限以及相关限制,许多患者无法完成治疗。在本研究中,我们报告了源自海洋海绵Theonella sp.的onnamides对硕大利什曼原虫前鞭毛体形式具有显著的杀利什曼活性(IC = 0.2 - 140 nM),并通过对人肝癌HepG2细胞的细胞毒性评估证明了它们的选择性。使用6,7 - 二氢 - onnamide A及其类似物进行了构效关系(SAR)分析。此外,我们比较了目前用于治疗的主要药物两性霉素B和所获得的onnamides的作用机制。基于生物学评估和SAR研究,onnamides可被视为抗利什曼化疗的有前景候选药物,值得进一步研究。